(Q35088019)

English

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA. (English)

1 reference

Europe PubMed Central

6 August 2017

5

object named as

Sam S Chang

1 reference

Europe PubMed Central

6 August 2017

author name string

David J Grossklaus

1

1 reference

Europe PubMed Central

6 August 2017

Joseph A Smith

2

1 reference

Europe PubMed Central

6 August 2017

Scott B Shappell

3

1 reference

Europe PubMed Central

6 August 2017

Christopher S Coffey

4

1 reference

Europe PubMed Central

6 August 2017

Michael S Cookson

6

1 reference

Europe PubMed Central

6 August 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

6 August 2017

Urologic Oncology

1 reference

Europe PubMed Central

6 August 2017

7

1 reference

Europe PubMed Central

6 August 2017

5

1 reference

Europe PubMed Central

6 August 2017

195-198

1 reference

Europe PubMed Central

6 August 2017

Serum concentrations of prostate specific antigen and its complex with alpha 1-antichymotrypsin before diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of percent free prostate specific antigen for staging clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of three molecular forms of prostate-specific antigen ratios in patients with prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2802%2900190-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1078-1439(02)00190-4

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35088019&oldid=1990497048"